Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massar Omar

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Heart Failure|February 4, 2022
Diabesity and heart failure with preserved ejection fraction: the picture is getting clearerMassar Omar, Michael D Jensen, Barry A Borlaug
The Lancet. Diabetes & Endocrinology|April 17, 2021
Fluid volume regulation in patients with heart failure - Authors' replyJesper Jensen, Massar Omar, Jacob Eifer Møller, et al.
American Heart Journal|April 27, 2021
Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial"Jesper Jensen, Massar Omar, Jacob Eifer Møller, et al.
JACC. Heart Failure|December 31, 2021
Reply: Accelerometers: A Useful Technology in HF Research?Massar Omar, Jesper Jensen, Morten Schou, et al.
Basic & Clinical Pharmacology & Toxicology|May 5, 2022
Sodium-glucose co-transporter-2 inhibitors in heart failure with reduced ejection fraction: Current evidence and future perspectivesJesper Jensen, Massar Omar, Caroline Kistorp, et al.
Mayo Clinic Proceedings|August 6, 2025
Acute Effects of Myeloperoxidase Inhibition on Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical TrialDejana Popovic, Yogesh N V Reddy, Massar Omar, et al.
JHEP Reports : Innovation in Hepatology|April 22, 2026
Haemodynamic alterations associated with hepatic vascular malformations in hereditary haemorrhagic telangiectasia: a cohort studyPernille Darre Haahr, Mikael Kjær Poulsen, Jens Kjeldsen, et al.
European Journal of Heart Failure|April 18, 2023
Biventricular cardiac power reserve in heart failure with preserved ejection fractionAlessio Alogna, Massar Omar, Dejana Popovic, et al.
Nordic Journal of Psychiatry|April 7, 2021
Cardiovascular autonomic neuropathy in patients with schizophreniaMassar Omar, Emilie Sylvest Wieben, Christoffer Polcwiartek, et al.
European Journal of Heart Failure|November 24, 2022
Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoeaKazunori Omote, Frederik H Verbrugge, Hidemi Sorimachi, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Heart Failure|February 4, 2022
Diabesity and heart failure with preserved ejection fraction: the picture is getting clearerMassar Omar, Michael D Jensen, Barry A Borlaug
The Lancet. Diabetes & Endocrinology|April 17, 2021
Fluid volume regulation in patients with heart failure - Authors' replyJesper Jensen, Massar Omar, Jacob Eifer Møller, et al.
American Heart Journal|April 27, 2021
Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial"Jesper Jensen, Massar Omar, Jacob Eifer Møller, et al.
JACC. Heart Failure|December 31, 2021
Reply: Accelerometers: A Useful Technology in HF Research?Massar Omar, Jesper Jensen, Morten Schou, et al.
Basic & Clinical Pharmacology & Toxicology|May 5, 2022
Sodium-glucose co-transporter-2 inhibitors in heart failure with reduced ejection fraction: Current evidence and future perspectivesJesper Jensen, Massar Omar, Caroline Kistorp, et al.
Mayo Clinic Proceedings|August 6, 2025
Acute Effects of Myeloperoxidase Inhibition on Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical TrialDejana Popovic, Yogesh N V Reddy, Massar Omar, et al.
JHEP Reports : Innovation in Hepatology|April 22, 2026
Haemodynamic alterations associated with hepatic vascular malformations in hereditary haemorrhagic telangiectasia: a cohort studyPernille Darre Haahr, Mikael Kjær Poulsen, Jens Kjeldsen, et al.
European Journal of Heart Failure|April 18, 2023
Biventricular cardiac power reserve in heart failure with preserved ejection fractionAlessio Alogna, Massar Omar, Dejana Popovic, et al.
Nordic Journal of Psychiatry|April 7, 2021
Cardiovascular autonomic neuropathy in patients with schizophreniaMassar Omar, Emilie Sylvest Wieben, Christoffer Polcwiartek, et al.
European Journal of Heart Failure|November 24, 2022
Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoeaKazunori Omote, Frederik H Verbrugge, Hidemi Sorimachi, et al.
Pageof 5